Bicyclic melanocortin-specific compounds
US7326707B2 · kind B2 · utility
14Cited by
29References
56Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2004 |
| Grant date | Feb 5, 2008 |
| Priority date | — |
| Expiry date | Apr 1, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Melanocortin receptor-specific bicyclic compounds having the structure:and stereoisomer and pharmaceutically acceptable salts thereof, where R1, R2, R3 X and z are as described in the specification, which are agonists, antagonists or mixed agonists and antagonists at one or more melanocortin receptors, and having utility in the treatment of melanocortin receptor-related disorders and conditions. Pharmaceutical compositions containing a compound of structure (I) and methods relating to the use thereof are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.